Search clinical trials for: Maraviroc/Dapivirine Gel

Total 3074 results

International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium

HIV Infections
International Partnership for Microbicides, Inc.

Completed

Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

HIV Infections

United States
International Partnership for Microbicides, Inc.

Completed

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

HIV Infections

Belgium
International Partnership for Microbicides, Inc.

Completed

A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

HIV-1 Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults

HIV Infections

United States, Thailand
International Partnership for Microbicides, Inc.

Completed

Assessing the Safety of Dapivirine Gel and Film Formulations

HIV Infections

United States
International Partnership for Microbicides, Inc.

Withdrawn

Dapivirine Gel Rectal Safety and PK Study

HIV 1 Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults

HIV Infections

United States
International Partnership for Microbicides, Inc.

Completed

PK/PD of Single Dose Dapivirine Vaginal Film

Pharmaokinetics
International Partnership for Microbicides, Inc.

Withdrawn

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa

HIV Infections
International Partnership for Microbicides, Inc.

Completed

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium

HIV Infections | HIV-1

Belgium
International Partnership for Microbicides, Inc.

Completed

A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel

HIV Infections

Rwanda, South Africa, Tanzania
International Partnership for Microbicides, Inc.

Completed

A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel

HIV Infections

South Africa
International Partnership for Microbicides, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings

HIV-1-infection

United States
International Partnership for Microbicides, Inc.

Completed

A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

HIV Infections

Belgium
International Partnership for Microbicides, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults

HIV/AIDS

United States
International Partnership for Microbicides, Inc.

Completed

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

HIV Infections | Acquired Immunodeficiency Syndrome

Kenya, Malawi, Rwanda, South Africa, Tanzania
International Partnership for Microbicides, Inc.

Completed

A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring

HIV Infections

Belgium
International Partnership for Microbicides, Inc.

Completed

A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine

HIV
International Partnership for Microbicides, Inc.

Active, not recruiting

Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008

HIV Infections

South Africa
International Partnership for Microbicides, Inc.

Completed

Expanded Use PK of Dapivirine Vaginal Ring

Pharmacokinetics
International Partnership for Microbicides, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women (ASPIRE)

HIV Infections

Malawi, South Africa, Uganda, Zimbabwe
International Partnership for Microbicides, Inc.

Completed

Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women

Human Immunodeficiency Virus

United States
International Partnership for Microbicides, Inc.

Completed

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

HIV Infections | Acquired Immunodeficiency Syndrome | Healthy

South Africa
International Partnership for Microbicides, Inc.

Completed

Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women

Human Immunodeficiency Virus

Malawi, South Africa, Uganda, Zimbabwe
International Partnership for Microbicides, Inc.
National Institutes of Health (NIH); Microbicide Trials Network

Completed

Study of Dapivirine Vaginal Ring (VR) in Adolescents

Human Immunodeficiency Virus

United States
International Partnership for Microbicides, Inc.

Completed

Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures

Topical Penile Exposures

United States
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

HIV Infections

Belgium
International Partnership for Microbicides, Inc.

Completed

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

HIV Infections

South Africa, Uganda
International Partnership for Microbicides, Inc.

Completed

To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women

HIV Prevention

South Africa, Uganda
International Partnership for Microbicides, Inc.

Completed

Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring

HIV Infections

Belgium
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

HIV Infections

Belgium
International Partnership for Microbicides, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women

Human Immunodeficiency Virus

United States
Zonguldak Bulent Ecevit University

Completed

Effect of Different Supralottic Airway Devicess on Optic Nerve Sheath Diameter

Intracranial Pressure Increase | Supraglottic Airway Device | Optic Nerve Sheath Diameter

Turkey
Abramson Cancer Center of the University of Pennsylvania

Completed

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft-versus-host Disease
ViiV Healthcare
Pfizer

Completed

Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

Healthy

Belgium
ViiV Healthcare
Pfizer

No longer available

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Human Immunodeficiency Virus (HIV)
University of Massachusetts, Worcester

Completed

Intratumoral Injection Of Alpha-Gal Glycosphingolipids

Metastatic Melanoma

United States
Kirby Institute

Completed

MARCH Vascular Endothelium Substudy (MARCH VE)

Cardiovascular Disease

Argentina, Australia, Germany, Thailand
Ahmed A. H. Abdellatif

Unknown

Topical Silver Nanoparticles for Microbial Activity

Infection, Bacterial | Foot Infection Fungal

Saudi Arabia
Glyciome, LLC
Brigham and Women's Hospital; University of Puerto Rico

Completed

Perception & Acceptability of a Cervical Cancer Prevention Prebiotic Device

Sensory Perceptual Characteristics | User Acceptability of Gel Delivery System

United States, Puerto Rico
Starpharma Pty Ltd

Completed

Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

Bacterial Vaginosis

United States
Novan, Inc.

Completed

A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

Acne Vulgaris

Dominican Republic, Honduras, Panama
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
Starpharma Pty Ltd

Completed

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

Recurrent Bacterial Vaginosis (BV)
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population

HIV Infections

South Africa, Uganda, Zimbabwe
DermBiont, Inc.

Active, not recruiting

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

Tinea Pedis

United States
International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

HIV Infections

South Africa, Malawi, Rwanda, Zimbabwe
Alcon Research

Completed

In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients

Dry Eye Syndrome
Population Council

Completed

Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women

HIV Infection

United States

Search clinical trials for: Maraviroc/Dapivirine Gel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations